to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Tina Seelig is the Executive Director for the Stanford Technology Ventures Program where she is responsible for the management, operations, and dissemination efforts of STVP. In addition, Tina is the Director of the
Stanford Entrepreneurship Network and the co-Director of the Mayfield Fellows Program. Tina also teaches a course in the Department of Management Science & Engineering on Creativity and Innovation. Prior to joining STVP, Tina worked as
an entrepreneur, management consultant, author, and scientist. Tina received her Ph.D. from Stanford University Medical School in 1985 where she studied Neuroscience. Tina has worked as management consultant for Booz, Allen, and Hamilton,
has written several popular science books and has designed a series of educational games. Her books include The Epicurean Laboratory, Incredible Edible Science, and a series called Games for Your Brain. After Tina's first book was
published in 1991, she became interested in how books are marketed. This led her to start a company designed to help match books with buyers. The product was a multimedia system for bookstore customers, called BookBrowser. BookBrowser was
a kiosk-based system that allowed customers to identify books of interest. With the help of a team of engineers and graphic designers, Tina built the business and sold the company in 1993. After selling her business, Tina worked as a
Multimedia Producer for Compaq Computer Corporation. In this position Tina led a team of engineers, artists, scriptwriters, and education specialists through the design and implementation of a series of multimedia titles. Tina's current
position as Executive Director of the Stanford Technology Ventures Program takes advantage of her technical background, in addition to her experiences as a manager, entrepreneur, and educator.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Beth Seidenberg, partner at venture firm Kleiner Perkins Caufield &amp; Byers, speaks at length about KPCB's current areas of interest, and its litmus test for projects worth supporting. Seidenberg also offers a case study of a life sciences firm moving from research lab toward market.
A search for a joint-venture partner requires a thorough review, extensive due diligence and a list of key objectives and goals. This article explains how to go through the process.
Josh Schwarzapel is the Product Manager for Cooliris Shopping. Josh has work experience performing ﬁnancial analysis for Smith Barney, and working on a marketing team at Fox Sports. He also has substantial
non-proﬁt experience, having founded a bridge organization to connect Stanford student volunteers and Accion Emprendadora, a non- proﬁt organization in Chile that educates and provides micro-ﬁnancial
services to poor entrepreneurs.
Tom Siebel is Chairman of First Virtual Group, a diversified holding company with interests in commercial real estate, agribusiness, global investment management, and philanthropy. Siebel was the founder, chairman, and
CEO of Siebel Systems, which merged with Oracle Corporation in January 2006. Founded in 1993, Siebel Systems became a global leader in application software with more than 8,000 employees in 32 countries, over 4,500 corporate customers, and
annual revenue in excess of $2 billion. Prior to Siebel Systems, Siebel served as CEO of Gain Technology and held various management positions at Oracle. He is a frequent industry spokesman and the author of three books, including
Taking Care of eBusiness and Cyber Rules, published by Doubleday, and Virtual Selling, published by the Free Press. Siebel is a graduate of the University of Illinois at
Urbana-Champaign, where he received a BA in history, an MBA, a MS in computer science, and a PhD with honors in Engineering.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.